• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

What We're Reading: Food Allergy Prevalence; Right to Try Law; State Variation in Fertility Rates

Article

While 1 in 5 Americans say they have a food allergy, 1 in 10 actually do; a patient with a rare form of brain cancer is the first patient to be treated under the Right to Try Law; and federal data show significant variation in fertility rates around the country.

More Americans Say They Have Allergies Than Actually Have Them

While 1 in 5 Americans say they have a food allergy, many of them probably don’t, according to a study published in JAMA Network Open. Researchers surveyed over 40,000 adults and found that, although 19% of adults reported a food allergy, estimated food allergy prevalence among US adults is actually 10.8%, corresponding with more than 26 million adults. The most common allergy was shellfish, followed by milk, peanuts, tree nuts, fin fish, eggs, wheat, soy, and sesame.

First Patient Treated Under Right to Try Law

Fertility Rates Vary Greatly by State

A patient with an aggressive form of brain cancer has become the first patient in the United States to receive experimental treatment under the Right to Try law of 2017. After failing to qualify for clinical trial enrollment, the patient started receiving the experimental treatment ERC-1671 at the University of California, Irvine in November 2018, reported RAPS. The treatment is in phase 2 clinical trials.As the birthrate in the United States continues to decline, a new look at federal data has found significant variation in fertility rates around the country. States in the Midwest and Southeast have higher rates of fertility compared with the Northeast and West Coast. According to The Wall Street Journal, in 2017, there was a 57% difference between the highest state rate (South Dakota, 2227 births) and the lowest (District of Columbia, 1421 births). Hispanic women had the highest fertility rate of the ethnicities studied.

Related Videos
Pat Van Burkleo
Video 1 - "Diagnosing and Understanding the Pathogenesis of Bronchiectasis"
Video 4 - "Challenges in Autoantibody Screening for Type 1 Diabetes"
Jeff Stark, MD, vice president, head of medical immunology, UCB
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Video 6 - "Community Partnership: Increasing Public Awareness of CVD"
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.